Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease
